Small Molecules Shed Light On Cancer Therapies
8/23/2011
Patients suffering from an aggressive brain cancer will benefit from the results of a University of Illinois study that could advance the development of targeted gene therapies and improve prognosis...
Saffron Shows Promise In Preventing Liver Cancer
8/23/2011
The full study of a new research indicating that Saffron has a significant chemopreventive effect against liver cancer in animals is published in the September issue of Hepatology, a journal published by Wiley Blackwell on behalf of the American Association for the Study of Liver Diseases...
Treatments For Breast And Colon Cancers Explored By UH Researchers
8/23/2011
University of Houston (UH) researchers have their sights set on developing possible treatments for breast and colon cancer...
Radioembolization Improves Survival Chances Of Liver Cancer Patients
8/23/2011
According to the largest to-date multi-center study in Europe, published in the September issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, survival for patients with hepatocellular carcinoma (HCC) can be achieved by using 90Y-resin microsphere radioembolization...
Ovarian Cancer Drug Olaparib Offers Hope For Patients Without BRCA Mutations
8/23/2011
According to an article published online first in the Lancelot Oncology, findings revealed the potential of olaparib to treat patients with more common sporadic (non-hereditary) tumors which could offer a new treatment option for one of the most deadly cancers in women...
Hepatitis G Virus May Cause Liver Cancer
8/23/2011
Hepatitis G virus was identified in 1995. Some little research was carried out on the virus and the US Food and Drug Administration (FDA) declared it a non-harmful virus in 1997. Researchers in Saudi Arabia, writing in the International Journal of Immunological Studies present evidence to suggest that this may have been the wrong decision...
The toxicities associated with aromatase inhibitors (AIs) may explain the lack of overall survival improvement compared with tamoxifen, according to a study published August 22 in the Journal of The National Cancer Institute. AIs are a class of drugs used to treat breast cancer in postmenopausal women...
Research Looks At Developing A Bull's-Eye Therapy To Combat Lung Cancer
8/23/2011
A Kansas State University professor is trying to create a patient-friendly treatment to help the more than 220,000 people who are diagnosed with lung cancer each year. Masaaki Tamura, associate professor of anatomy and physiology, and his research team are working on several projects that use nanoparticles to treat and directly target the "bull's-eye": cancer cells...
17% Of Cancer Nurses Unintentionally Exposed To Chemotherapy
8/23/2011
Nearly 17 percent of nurses who work in outpatient chemotherapy infusion centers reported being exposed on their skin or eyes to the toxic drugs they deliver, according to a new study from the University of Michigan Comprehensive Cancer Center. The study surveyed 1,339 oncology nurses from one state who did not work in inpatient hospital units...
Radioembolization Improves Chance Of Survival For Liver Cancer Patients
8/23/2011
Analysis revealed survival for patients with hepatocellular carcinoma (HCC) is achievable using 90Y-resin microsphere radioembolization. The analysis conducted at multiple centers across Europe showed that the procedure is likely to provide survival benefit across different tumor stages, including patients with advanced liver cancer and with limited treatment options...